| 4916 |
Centers for Disease Control and Prevention |
Html |
en |
Overview of a Pandemic - Detection of the 2009 H1N1 Virus |
null |
| expert assessments | 0.246465 |
| respiratory illness outbreaks | 0.517136 |
| Retrospective evidence | 0.326351 |
| World Health Organization | 0.443124 |
| scientific criteria | 0.248518 |
| CDC Seasonal Flu | 0.643148 |
| novel influenza | 0.406623 |
| available evidence | 0.293437 |
| influenza pandemic alert | 0.92733 |
| human flu virus | 0.731243 |
|
| English language content | 0.544793 |
| National Public Health | 0.468582 |
| H1N1 virus | 0.373547 |
| stand-alone Web document | 0.512202 |
| Global pandemic | 0.593937 |
| 2009 influenza pandemic | 0.961333 |
| reference purposes | 0.295017 |
| PowerPoint presentation | 0.274438 |
| Section 508-accessible version | 0.493981 |
|
CLICK HERE |
| 5556 |
Centers for Disease Control and Prevention |
Html |
en |
Carbaryl - NIOSH Pocket Guide to Chemical Hazards |
null |
| MPEG | 0.378858 |
| search | 0.263099 |
| PDF | 0.261307 |
| PPT | 0.446092 |
|
| DOC | 0.368812 |
| information | 0.262482 |
| different file formats | 0.938484 |
| page | 0.276773 |
|
CLICK HERE |
| 5885 |
Centers for Disease Control and Prevention |
Html |
en |
Cyclopentadiene - NIOSH Pocket Guide to Chemical Hazards |
null |
| MPEG | 0.378858 |
| search | 0.263099 |
| PDF | 0.261307 |
| PPT | 0.446092 |
|
| DOC | 0.368812 |
| information | 0.262482 |
| different file formats | 0.938484 |
| page | 0.276773 |
|
CLICK HERE |
| 6588 |
Centers for Disease Control and Prevention |
Html |
en |
Notifiable Diseases and Mortality Tables - January 27, 2012 |
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. |
| provisional 4-week totals | 0.784874 |
| Mortality Tables | 0.477141 |
| equine encephalitis virus | 0.622274 |
| Mortality Weekly Report | 0.477882 |
| Viral hemorrhagic fever¶¶¶ | 0.460176 |
| provisional cases | 0.69277 |
| Hantavirus pulmonary syndrome§ | 0.463779 |
| Staphylococcus aureus§ | 0.461394 |
| New York City | 0.44693 |
| acute hepatitis | 0.500723 |
| 2011-12 influenza season | 0.477091 |
| noncholera Vibrio species | 0.459928 |
| influenza A virus | 0.484096 |
| National Center | 0.584399 |
| CDC Home CDC | 0.487069 |
| Hemolytic uremic syndrome | 0.465607 |
| California serogroup virus | 0.508464 |
| meningococcal disease | 0.543934 |
| historical data | 0.543499 |
| Influenza Division | 0.458349 |
| Ñ?ЛП
Notifiable Diseases | 0.543592 |
| Cumulative year-to-date counts | 0.456713 |
| 2009 pandemic | 0.51365 |
| Respiratory Diseases | 0.449763 |
|
| NN | 0.452598 |
| United States | 0.946881 |
| Vancomycin-resistant Staphylococcus aureus§ | 0.456943 |
| novel influenza | 0.551221 |
| I. Provisional cases | 0.528175 |
| 5-year weekly average†| 0.48599 |
| notifiable diseases | 0.854585 |
| Vancomycin-intermediate Staphylococcus aureus§ | 0.456238 |
| Eastern equine encephalitis | 0.477622 |
| pandemic influenza | 0.523167 |
| Influenza-associated pediatric mortality§ | 0.457008 |
| viral hemorrhagic fever | 0.449068 |
| New York | 0.459829 |
| Western equine encephalitis | 0.476934 |
| Polio virus Infection | 0.468822 |
| Total case counts | 0.449998 |
| notifiable disease reports | 0.760722 |
| current 4-week total | 0.48863 |
| Vector-Borne Infectious Diseases | 0.464365 |
| Chlamydia trachomatis infection | 0.447967 |
| TABLE I. | 0.480251 |
| dengue hemorrhagic fever | 0.45224 |
| subsequent 4-week periods | 0.473894 |
| West Nile virus | 0.464404 |
|
CLICK HERE |
| 6936 |
Centers for Disease Control and Prevention |
Html |
en |
Notes from the Field: Multistate Outbreak of Postprocedural Fungal Endophthalmitis Associated with a Single Compounding Pharmacy - United States, March-April 2012 |
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. |
| Rachel Smith | 0.619126 |
| sterile preparations | 0.657014 |
| pars plana vitrectomies | 0.624771 |
| MMWR HTML versions | 0.623084 |
| professional ophthalmology societies | 0.622882 |
| electronic PDF version | 0.61732 |
| invasive ophthalmic procedure | 0.626815 |
| state health departments | 0.658871 |
| probable cases | 0.614592 |
| States Pharmacopeia-National Formulary | 0.624453 |
| intravitreal injections | 0.640976 |
| ongoing investigation | 0.623406 |
| incarnatum-equiseti species | 0.637456 |
| BBG dye | 0.807755 |
| local health alerts | 0.670346 |
| Franck | 0.720512 |
| triamcinolone-containing products | 0.701262 |
| York City Dept | 0.637181 |
| intravitreal injection | 0.70771 |
| postprocedure adverse events | 0.629096 |
| mold Bipolaris hawaiiensis | 0.62855 |
| Angeles County Department | 0.648725 |
| ambulatory surgical center | 0.640316 |
| original paper copy | 0.611501 |
|
| sterile compounded products | 0.748392 |
| current investigative findings | 0.628737 |
| root cause | 0.620976 |
| different compounding pharmacy | 0.618867 |
| Public Health | 0.970385 |
| original MMWR paper | 0.622174 |
| U.S. Government Printing | 0.618089 |
| genetic sequencing | 0.637618 |
| possible fungal infection | 0.640157 |
| United States Pharmacopeia | 0.62804 |
| F. incarnatum-equiseti species | 0.632113 |
| Christina Mikosz | 0.619469 |
| local health departments | 0.681291 |
| Kavita K. Trivedi | 0.620682 |
| Career Epidemiology Field | 0.611471 |
| FDA MedWatch alerts | 0.629197 |
| adverse events | 0.68515 |
| ClinMicroNet microbiology laboratories | 0.621265 |
| Angeles County Dept | 0.641264 |
| Public Health Preparedness | 0.666009 |
| Indiana State Dept | 0.646402 |
| repeat ophthalmic surgery | 0.630102 |
| Fusarium incarnatum-equiseti species | 0.636935 |
| available isolates | 0.645391 |
|
CLICK HERE |
| 7147 |
Centers for Disease Control and Prevention |
Html |
en |
Global Health - Sudan |
null |
| Content source | 0.892652 |
| HHS | 0.699811 |
| endorsement | 0.682673 |
| CDC | 0.617915 |
|
| non-federal site | 0.998525 |
| Notice | 0.617482 |
| sponsors | 0.49087 |
| information | 0.490002 |
|
CLICK HERE |
| 8900 |
Centers for Disease Control and Prevention |
Html |
en |
Malaria - Travelers - Choosing a Drug to Prevent Malaria |
Education and information regarding choosing a drug to prevent malaria, including a list of all available drugs and reasons for taking or not taking a certain drug. |
| rheumatologic conditions | 0.392761 |
| weekly medication | 0.473447 |
| comparable efficacy | 0.407328 |
| drug needs | 0.46686 |
| drug-drug interactions | 0.40167 |
| pregnant women | 0.473062 |
| normal G6PD level | 0.4553 |
| G6PD deficiency | 0.443444 |
| insecticide-treated bednet | 0.410726 |
| drug allergies | 0.403696 |
| alphabetical order | 0.403395 |
| certain psychiatric conditions | 0.453646 |
| mefloquine resistance | 0.497072 |
| glucose-6-phosphatase dehydrogenase | 0.387492 |
| decision process | 0.400568 |
| insect repellent | 0.403533 |
| medical contraindications | 0.404365 |
| Yellow Book | 0.40283 |
| malaria differ | 0.41746 |
| cardiac conduction abnormalities | 0.458503 |
| seizure disorder | 0.388218 |
| effective medicine | 0.397081 |
| shorter trips | 0.471861 |
| following table | 0.400597 |
| good choice | 0.977934 |
|
| long pants | 0.401752 |
| upset stomach | 0.485209 |
| long duration | 0.405811 |
| different medicine | 0.39829 |
| P. vivax | 0.461266 |
| different drugs | 0.396125 |
| personal protective measures | 0.482787 |
| daily medicine | 0.561869 |
| severe renal impairment | 0.475026 |
| additional medicine | 0.475526 |
| vaginal yeast infections | 0.458691 |
| considerable sun exposure | 0.457113 |
| medicine | 0.667512 |
| short duration | 0.582285 |
| people | 0.778207 |
| long trips | 0.461726 |
| malaria transmission | 0.589672 |
| trips | 0.48935 |
| antimalarial drug | 0.414227 |
| mosquito-free setting | 0.405141 |
| last-minute travelers | 0.868921 |
| country-specific tables | 0.408285 |
| Pediatric tablets | 0.398831 |
| fresh water | 0.387441 |
|
CLICK HERE |
| 10071 |
Centers for Disease Control and Prevention |
Html |
en |
CDC - Features -Birth Defects Findings Terms - NCBDDD |
null |
| general public | 0.55553 |
| birth conditions | 0.567925 |
| findings | 0.510342 |
| body | 0.519797 |
| individuals | 0.510282 |
| research | 0.519927 |
| preferred phrase | 0.61411 |
| mental retardation | 0.555503 |
| birth disorders | 0.569177 |
| Birth Defects Res | 0.68686 |
| common phrase | 0.605842 |
| function | 0.519815 |
| previous studies | 0.557064 |
| Birth Defects Terminology | 0.686457 |
| Petersen EE | 0.55682 |
| family members | 0.555907 |
| A. Public Perception | 0.59822 |
| article | 0.520036 |
| best serve people | 0.591821 |
| respondents | 0.584709 |
| phrase | 0.646688 |
| publicly accepted term | 0.5979 |
| negative view | 0.5558 |
| intellectual disability | 0.554179 |
| journal Birth Defects | 0.728178 |
|
| adverse pregnancy outcomes | 0.606314 |
| proportion | 0.513272 |
| congenital malformations | 0.563179 |
| congenital anomalies | 0.561329 |
| nationally representative survey | 0.601047 |
| Mai CT | 0.553097 |
| common terminology | 0.554099 |
| negative connotation | 0.565456 |
| epub | 0.513804 |
| new study online | 0.616633 |
| nationally representative sample | 0.611252 |
| special issue | 0.561835 |
| summary | 0.511138 |
| Birth Defects Terminology. | 0.726893 |
| special needs | 0.555772 |
| visit www.cdc.gov/birthdefects | 0.551871 |
| suitable phrase | 0.596832 |
| support groups | 0.550865 |
| concerns | 0.5208 |
| birth defects | 0.954073 |
| well-recognized phrase | 0.620585 |
| Public Perception | 0.612376 |
| health groups | 0.55361 |
| structure | 0.519828 |
|
CLICK HERE |
| 11527 |
Centers for Disease Control and Prevention |
Html |
en |
NCIRD | About Division of Bacterial Diseases |
null |
| briefing documents | 0.240304 |
| DBD programs | 0.327139 |
| vaccine-preventable disease | 0.643781 |
| policy matters | 0.223914 |
| respiratory bacterial diseases | 0.943723 |
| Accelerate development | 0.492172 |
| bacterial vaccines | 0.718602 |
| Page | 0.235641 |
| outbreak investigations | 0.255669 |
| adapt existing methods | 0.409897 |
| laboratory science | 0.269085 |
| vaccine-preventable disease issues | 0.596505 |
| epidemiologic | 0.235726 |
| policy implications | 0.226633 |
| pathogen characterization | 0.277659 |
| new methods | 0.219418 |
| critical role | 0.265305 |
|
| statistical applications | 0.220442 |
| National Center | 0.266257 |
| interested stakeholders | 0.227551 |
| outbreak response | 0.299461 |
| vaccine development | 0.263765 |
| ongoing surveillance | 0.222533 |
| bacterial pathogens | 0.498505 |
| Provide statistical consultation | 0.398411 |
| legislative proposals | 0.230827 |
| bacterial respiratory | 0.720707 |
| laboratory diagnosis | 0.265192 |
| laboratory research studies | 0.763635 |
| ongoing Division activities | 0.391125 |
| primary contact | 0.238353 |
| Respiratory Diseases | 0.445431 |
| congressional testimony | 0.23405 |
| vaccine-preventable diseases | 0.418715 |
|
CLICK HERE |
| 14272 |
Centers for Disease Control and Prevention |
Html |
es |
Sífilis y los hombres que tienen relaciones sexuales con hombres - Hoja informativa de los CDC |
Sífilis y los hombres que tienen relaciones sexuales con hombres: Hoja informativa de los CDC |
| Archivo Apple Quicktime | 0.629398 |
| Archivo Microsoft PowerPoint | 0.651972 |
| Archivo Adobe PDF | 0.625715 |
| alto riesgo | 0.55208 |
| Estados Unidos | 0.763632 |
| Archivo Microsoft | 0.941593 |
| Archivo Microsoft Word | 0.648381 |
|
| múltiples parejas | 0.554742 |
| medicamentos correctos | 0.529695 |
| largo plazo | 0.796786 |
| Archivo Zip Comprimido | 0.625166 |
| única forma | 0.522516 |
| tantos sÃntomas | 0.547882 |
| Archivo Microsoft Excel | 0.622424 |
|
CLICK HERE |